DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Cover Tip

November 16, 2023
 IGV-001 Phase 2b Clinical Trial

Imvax is conducting a clinical trial to assess the safety and efficacy of IGV-001, an autologous biologic-device combination product in GBM patients.

Read More
September 6, 2023
Gleolan Tumor Imaging Agent

Gleolan Brain Dye, imaging agent, helps neurosurgeons to see “high grade gliomas” during surgery. Learn about Gleolan.

Read More
September 2, 2023
rGBM Study

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

Read More
September 2, 2023
PROSPECT PCNSL Study

PROSPECT is an open-label, Phase II study evaluating the efficacy, safety, and pharmacokinetics of an oral medicine called Tirabrutinib.

Read More
May 17, 2023
Imvax Immunotherapy Clinical Study

Imvax is conducting a new phase 2b clinical study, with a combination immunotherapy, for newly diagnosed patients with glioblastoma.

Read More
March 27, 2023
What Are Decentralized Clinical Trials, eConsent, How to Access and Can They Help YOU?

In decentralized Clinical Trials some or all trial-related procedures and compiling of patient and trial data takes place at locations/sites that are remote from the Principal Investigator.

Read More
February 15, 2023
DISEASE EDUCATION & CALLING ALL HEALTH AND INCREASED PATIENT ACCESS INVESTORS

This Month, I’d like to introduce you to the company, Reglagene, www.reglagene.com, a therapeutics company located in Tucson, AZ transforming tubulin targeting therapy for CNS diseases.

Read More
February 13, 2023
DISEASE EDUCATION: What is Proton Therapy?

An advanced and highly precise form of radiation treatment is known as Proton Therapy (PT). PT minimizes damage to the surrounding tissue and risk of short- and long-term side effects because it allows radiation specialists to focus radiation directly into the tumor.

Read More
February 6, 2023
Advances in Precision Medicine, NGS Testing, and Breaking the Barriers with Clinical Trials

Targeted therapies are a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. They are the foundation of precision medicine. May12, 2023

Read More
December 3, 2022
"20 Years of Increasing Patient ACCESS” to Specialists, Advanced Treatment Options, INCLUDING Treatments that are Standard of Care or FDA Approved that Patients are NOT Offered, Diagnostics and Clinical Trials

The End Brain Cancer Initiative (EBCI) and I are once again thrilled to have this platform to increase patient education, awareness & outreach to the global brain tumor community and to the general public with the goal of increasing their direct access to top brain tumor specialists at brain tumor centers of excellence, multiple treatment options/diagnostics and clinical trials.

Read More
October 5, 2022
ADVOCACY & DISEASE EDUCATION: PDUFA

PDUFA, the Prescription Drug User Fee Acts, ensures the FDA retains its capacity to promote the health and well-being of all Americans for another five years.

Read More
October 3, 2022
INCREASING PATIENT DISEASE EDUCATION, AWARENESS & OUTREACH FOR GREATER ACCESS TO ADVANCED DIAGNOSTICS, SPECIALISTS AND TREATMENT OPTIONS/CLINICAL TRIALS WITH ENDEAVOR BIOMEDICINES

If you have a solid tumor, you may benefit from an additional test called Next Generation Sequencing (NGS), which looks at the genes associated with cancer.

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram